Publications
ProMab's goal to become one of the leading providers in antibody development, CAR-T research & immunotherapy space allows us to post our findings on accredited research publications. In addition, many of our clients and collaborators use our services to advance their own research. Visit this page to view some of our accomplishments and check the link below if you are interested in reading more. <p>> PMC search</p>
A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells.
Xi B, Berahovich R, Zhou H, Xu S, Wei Y, Guan J, Harto H, Guan J, Wu L, Santa Ana D, Cerignoil F, Lamarche B4, Abassi YA, Golubovskaya V.
Hypoxia Selectively Impairs CAR-T Cells In Vitro.
Berahovich R, Liu X, Zhou H, Tsadik E, Xu S, Golubovskaya V, Wu L.
Generation of CAR-T Cells for Cancer Immunotherapy.
Xu Q, Harto H, Berahovich R, Xu S, Zhou H, Golubovskaya V, Wu L.
CAR-T Cells Based on Novel BCMA Monoclonal Antibody Block Multiple Myeloma Cell Growth.
Berahovich R, Zhou H, Xu S, Wei Y, Guan J, Guan J, Harto H, Fu S, Yang K, Zhu S, Li L, Wu L, Golubovskaya V.
GITR domain inside CAR co-stimulates activity of CAR-T cells against cancer.
Golubovskaya VM, Berahovich R, Xu Q, Zhou H, Xu S, Guan J, Harto H, Li L, Wu L.
CAR-T Cell Therapy: From the Bench to the Bedside.
Golubovskaya V.
CD47-CAR-T Cells Effectively Kill Target Cancer Cells and Block Pancreatic Tumor Growth.
Golubovskaya V, Berahovich R, Zhou H, Xu S, Harto H, Li L, Chao CC, Mao MM, Wu L.
FLAG-tagged CD19-specific CAR-T cells eliminate CD19-bearing solid tumor cells in vitro and in vivo.
Berahovich R, Xu S, Zhou H, Harto H, Xu Q, Garcia A, Liu F, Golubovskaya VM, Wu L.
Major Highlights of the CAR-TCR Summit, Boston, 2016.
Golubovskaya V, Berahovich R, Xu S, Harto H, Wu L.
Different Subsets of T Cells, Memory, Effector Functions, and CAR-T Immunotherapy.
Golubovskaya V, Wu L.
Transferrin epitope-CD19-CAR-T cells effectively kill lymphoma cells in vitro and in vivo.
Valentine M., Le Li,, Hua Zhou, Shirley Xu, Jinying Sun, Chengjing Liu, Hizkia Harto, Robert Berahovich, Vita Golubovskaya, Lijun Wu,
Novel CD37, Humanized CD37 and Bi-Specific Humanized CD37-CD19 CAR-T Cells Specifically Target Lymphoma
Golubovskaya, V.; Zhou, H.; Li, F.; Valentine, M.; Sun, J.; Berahovich, R.; Xu, S.; Quintanilla, M.; Ma, M.C.; Sienkiewicz, J.; Huang, Y.; Wu, L.
Novel CS1 CAR-T Cells and Bispecific CS1-BCMA CAR-T Cells Effectively Target Multiple Myeloma
Golubovskaya, V.; Zhou, H.; Li, F.; Berahovich, R.; Sun, J.; Valentine, M.; Xu, S.; Harto, H.; Sienkiewicz, J.; Huang, Y.; Wu, L.
PLAP CAR-T cells mediate high specific cytotoxicity against colon cancer cells
Li X, Berahovich R, Zhou H, Liu X, Li F, Xu S, Wei Y, Ouaret D, Bodmer W, Wu L, Golubovskaya V
Bispecific BCMA-CD3 Antibodies Block Multiple Myeloma Tumor Growth
Wu L, Huang Y, Sienkiewicz J, Sun J, Guiang L, Li F, Yang L, Golubovskaya V.
mRNA-Lipid Nanoparticle (LNP) Delivery of Humanized EpCAM-CD3 Bispecific Antibody Significantly Blocks Colorectal Cancer Tumor Growth
Golubovskaya V, Sienkiewicz J, Sun J, Huang Y, Hu L, Zhou H, Harto H, Xu S, Berahovich R, Bodmer W, Wu L. mRNA-Lipid Nanoparticle (LNP) Delivery of Humanized EpCAM-CD3 Bispecific Antibody Significantly Blocks Colorectal Cancer Tumor Growth. Cancers (Basel
CAR-NK Cells Generated with mRNA-LNPs Kill Tumor Target Cells In Vitro and In Vivo
Golubovskaya V, Sienkiewicz J, Sun J, Zhang S, Huang Y, Zhou H, Harto H, Xu S, Berahovich R, Wu L. CAR-NK Cells Generated with mRNA-LNPs Kill Tumor Target Cells In Vitro and In Vivo. Int J Mol Sci. 2023 Aug 29;24(17):13364. doi: 10.3390/ijms241713364. PMI
HER2-CD3-Fc Bispecific Antibody-Encoding mRNA Delivered by Lipid Nanoparticles Suppresses HER2-Positive Tumor Growth
Liang Hu, Shiming Zhang, John Sienkiewicz, Hua Zhou, Robert Berahovich, Jinying Sun, Michael Li , Adrian Ocampo , Xianghong Liu , Yanwei Huang , Hizkia Harto , Shirley Xu , Vita Golubovskaya , Lijun Wu